These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32803286)

  • 1. Allopurinol use and prevention of gout attack.
    Lai SW; Kuo YH; Liao KF
    Eur J Clin Pharmacol; 2021 Jan; 77(1):145. PubMed ID: 32803286
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
    Wortmann RL; Macdonald PA; Hunt B; Jackson RL
    Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study.
    So MW; Lee SG; Kim YG; Lee CK; Yoo B
    Scand J Rheumatol; 2011 Nov; 40(6):444-7. PubMed ID: 21916803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attack of gout].
    Füessl HS
    MMW Fortschr Med; 2012 Jun; 154(11):56-8. PubMed ID: 22838134
    [No Abstract]   [Full Text] [Related]  

  • 5. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
    Chang HW; Lin YW; Lin MH; Lan YC; Wang RY
    PLoS One; 2019; 14(1):e0210085. PubMed ID: 30615649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure gout: failure to treat?
    Perry ME; Madhok R
    Rheumatology (Oxford); 2010 Dec; 49(12):2233-4. PubMed ID: 20463191
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ; Whallett A; Zaphiropoulos G
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of occupational gout.
    Conway R; Carey JJ; Coughlan RJ
    Ir Med J; 2011; 104(10):316-7. PubMed ID: 22256449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underscoring the Importance of Allopurinol in Treating Gout: Results of a Food and Drug Administration-Mandated Safety Trial.
    Nikolov NP; Seymour S; Neuner R; Hsueh YH; Andraca-Carrera E; Mistry K
    Arthritis Rheumatol; 2020 Jun; 72(6):877-878. PubMed ID: 32460423
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM; Sathischandra H; Jayamanne SF; de Silva HJ
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract]   [Full Text] [Related]  

  • 11. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
    Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
    Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of asymptomatic hyperuricemia].
    Floege J
    Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol--dose according to effect, not renal function.
    Bryant L
    J Prim Health Care; 2011 Dec; 3(4):323. PubMed ID: 22235497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic gout. Case report of a severe course of disease].
    Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
    Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
    [No Abstract]   [Full Text] [Related]  

  • 17. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
    Simon HB
    Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
    Lin HC; Daimon M; Wang CH; Ho Y; Uang YS; Chiang SJ; Wang LH
    Int J Cardiol; 2017 Apr; 233():85-90. PubMed ID: 28202260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.